| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |